Artificial intelligence in drug development for delirium and Alzheimer's disease - Ai, R; Xiao, X; Deng, S; Yang, N; Xing, X; Watne, LO; Wedatilake, Y; Xie, C; Selback, G; Rubinsztein, DC; Neerland, BE; Palmer, JE; et al. (Acta Pharmaceutica Sinica B, 2025)